Director Brian Belke receives 49,149 NextDecade (NEXT) restricted shares

Rhea-AI Filing Summary

NextDecade Corp director Brian Belke reported receiving 49,149 shares of restricted common stock on January 30, 2026. The grant was priced at $0 per share and increased his beneficial ownership to 440,919 shares of NextDecade common stock.

The filing notes these 49,149 restricted shares will vest on January 31, 2027, meaning Belke will gain full rights to them on that date if vesting conditions are met. This Form 4 reflects routine director equity compensation rather than an open‑market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Belke Brian

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	49,149	$0.00	--

Holdings After Transaction: Common Stock — 440,919 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Belke Brian

(Last) (First) (Middle)

1000 LOUISIANA STREET, SUITE 3300

(Street)

HOUSTON TX 77002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NextDecade Corp [ NEXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		49,149(1)	A	$0	440,919	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of restricted stock that will vest on January 31, 2027.

Remarks:

	/s/ Brian Belke	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NextDecade (NEXT) report in this Form 4?

NextDecade reported that director Brian Belke received 49,149 shares of restricted common stock on January 30, 2026. The shares were granted at $0 per share as equity compensation rather than purchased in the open market.

How many NextDecade (NEXT) shares does Brian Belke now beneficially own?

After this transaction, director Brian Belke beneficially owns 440,919 shares of NextDecade common stock. This total includes the newly granted 49,149 restricted shares reported in the filing, which will vest on January 31, 2027 if conditions are satisfied.

What are the terms of the restricted stock grant reported by NextDecade (NEXT)?

The filing shows a grant of 49,149 restricted shares of NextDecade common stock to director Brian Belke. According to the footnote, these restricted shares will vest on January 31, 2027, at which point he will gain full ownership rights to them.

Did Brian Belke pay cash for the NextDecade (NEXT) shares in this Form 4?

No cash changed hands in this transaction. The Form 4 reports that Brian Belke received 49,149 restricted shares of NextDecade common stock at a price of $0 per share, indicating a compensatory equity award rather than a market purchase.

Is the NextDecade (NEXT) Form 4 transaction a purchase, sale, or grant?

The Form 4 reflects an acquisition coded as “A” for a grant of restricted stock, not an open-market trade. Director Brian Belke was awarded 49,149 restricted shares, which will vest on January 31, 2027 according to the disclosure footnote.